secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0001213900-22-084016
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma shareholders approve reverse stock split up to 1:10 and increase authorized shares to 500M
--------------------------------------------------------------------------------

- Reverse stock split at ratio up to 1:10 approved with 30,927,745 votes for, 325,290 against.
- Authorized common shares increased from 95M to 500M; approved with 30,084,494 votes for, 1,171,098 against.
- Independent directors Gene Michael Bennett, Yingwen Zhang, Baowen Dong elected to serve until next annual meeting.
- Amended and Restated 2010 Long-Term Incentive Plan adopted; 27,482,540 votes for, 824,658 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022084016/0001213900-22-084016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022084016/ea171070-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-084016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer